APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tofacitinib

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Tofacitinib Market Analysis and Forecast 2026-2032

Report ID 174041700223 December 2025190 pages

Choose your research edition.

Industry ResearchTofacitinib Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Tofacitinib Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Tofacitinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tofacitinib Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Tofacitinib Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Tofacitinib market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tofacitinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Tofacitinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Tofacitinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Tofacitinib is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Tofacitinib include Pfizer, Globe Pharmaceuticals, Drug International, Delta Pharma Limited and Beacon Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tofacitinib, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Tofacitinib, also provides the sales of main regions and countries. Of the upcoming market potential for Tofacitinib, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tofacitinib sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Tofacitinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Tofacitinib sales, projected growth trends, production technology, application and end-user industry.

Tofacitinib Segment by Company

Pfizer

Globe Pharmaceuticals

Drug International

Delta Pharma Limited

Beacon Pharmaceuticals

Tofacitinib Segment by Type

5mg*60 Tablets

5mg*30 Tablets

5mg*14 Tablets

5mg*10 Tablets

10mg*14 Tablets

10mg*10 Tablets

Tofacitinib Segment by Application

Psoriasis

Rheumatoid Arthritis

Ulcerative Colitis

Others

Tofacitinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tofacitinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tofacitinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tofacitinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Tofacitinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Tofacitinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tofacitinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Tofacitinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5mg*60 Tablets Major Manufacturers Table 3. 5mg*30 Tablets Major Manufacturers Table 4. 5mg*14 Tablets Major Manufacturers Table 5. 5mg*10 Tablets Major Manufacturers Table 6. 10mg*14 Tablets Major Manufacturers Table 7. 10mg*10 Tablets Major Manufacturers Table 8. Global Tofacitinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Psoriasis Major Manufacturers Table 10. Rheumatoid Arthritis Major Manufacturers Table 11. Ulcerative Colitis Major Manufacturers Table 12. Others Major Manufacturers Table 13. Tofacitinib Industry Trends Table 14. Tofacitinib Industry Drivers Table 15. Tofacitinib Industry Opportunities and Challenges Table 16. Tofacitinib Industry Restraints Table 17. Global Tofacitinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Tofacitinib Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Tofacitinib Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Tofacitinib Revenue Market Share by Region (2021-2026) Table 21. Global Tofacitinib Revenue Market Share by Region (2027-2032) Table 22. Global Tofacitinib Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 23. Global Tofacitinib Sales by Region (2021-2026) & (k pcs) Table 24. Global Tofacitinib Sales by Region (2027-2032) & (k pcs) Table 25. Global Tofacitinib Sales Market Share by Region (2021-2026) Table 26. Global Tofacitinib Sales Market Share by Region (2027-2032) Table 27. Global Tofacitinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Tofacitinib Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Tofacitinib Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Tofacitinib Sales Market Share by Manufacturers (2021-2026) Table 31. Global Tofacitinib Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 32. Global Tofacitinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Tofacitinib Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Tofacitinib Manufacturers, Product Type & Application Table 35. Global Tofacitinib Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Tofacitinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Tofacitinib Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Tofacitinib Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Tofacitinib Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Tofacitinib Revenue Market Share by Type (2021-2026) Table 42. Global Tofacitinib Revenue Market Share by Type (2027-2032) Table 43. Global Tofacitinib Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 44. Global Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 45. Global Tofacitinib Sales by Type (2027-2032) & (k pcs) Table 46. Global Tofacitinib Sales Market Share by Type (2021-2026) Table 47. Global Tofacitinib Sales Market Share by Type (2027-2032) Table 48. Global Tofacitinib Price by Type (2021-2026) & (US$/pcs) Table 49. Global Tofacitinib Price by Type (2027-2032) & (US$/pcs) Table 50. Global Tofacitinib Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Tofacitinib Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Tofacitinib Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Tofacitinib Revenue Market Share by Application (2021-2026) Table 54. Global Tofacitinib Revenue Market Share by Application (2027-2032) Table 55. Global Tofacitinib Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 56. Global Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 57. Global Tofacitinib Sales by Application (2027-2032) & (k pcs) Table 58. Global Tofacitinib Sales Market Share by Application (2021-2026) Table 59. Global Tofacitinib Sales Market Share by Application (2027-2032) Table 60. Global Tofacitinib Price by Application (2021-2026) & (US$/pcs) Table 61. Global Tofacitinib Price by Application (2027-2032) & (US$/pcs) Table 62. Pfizer Company Information Table 63. Pfizer Business Overview Table 64. Pfizer Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 65. Pfizer Tofacitinib Product Portfolio Table 66. Pfizer Recent Development Table 67. Globe Pharmaceuticals Company Information Table 68. Globe Pharmaceuticals Business Overview Table 69. Globe Pharmaceuticals Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 70. Globe Pharmaceuticals Tofacitinib Product Portfolio Table 71. Globe Pharmaceuticals Recent Development Table 72. Drug International Company Information Table 73. Drug International Business Overview Table 74. Drug International Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 75. Drug International Tofacitinib Product Portfolio Table 76. Drug International Recent Development Table 77. Delta Pharma Limited Company Information Table 78. Delta Pharma Limited Business Overview Table 79. Delta Pharma Limited Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 80. Delta Pharma Limited Tofacitinib Product Portfolio Table 81. Delta Pharma Limited Recent Development Table 82. Beacon Pharmaceuticals Company Information Table 83. Beacon Pharmaceuticals Business Overview Table 84. Beacon Pharmaceuticals Tofacitinib Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 85. Beacon Pharmaceuticals Tofacitinib Product Portfolio Table 86. Beacon Pharmaceuticals Recent Development Table 87. North America Tofacitinib Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Tofacitinib Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 90. North America Tofacitinib Sales by Type (2027-2032) & (k pcs) Table 91. North America Tofacitinib Sales Price by Type (2021-2026) & (US$/pcs) Table 92. North America Tofacitinib Sales Price by Type (2027-2032) & (US$/pcs) Table 93. North America Tofacitinib Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Tofacitinib Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 96. North America Tofacitinib Sales by Application (2027-2032) & (k pcs) Table 97. North America Tofacitinib Sales Price by Application (2021-2026) & (US$/pcs) Table 98. North America Tofacitinib Sales Price by Application (2027-2032) & (US$/pcs) Table 99. North America Tofacitinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. North America Tofacitinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 101. North America Tofacitinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 102. North America Tofacitinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 103. North America Tofacitinib Sales by Country (2021-2026) & (k pcs) Table 104. North America Tofacitinib Sales by Country (2027-2032) & (k pcs) Table 105. North America Tofacitinib Sales Price by Country (2021-2026) & (US$/pcs) Table 106. North America Tofacitinib Sales Price by Country (2027-2032) & (US$/pcs) Table 107. United States Tofacitinib Revenue (2021-2032) & (US$ Million) Table 108. Canada Tofacitinib Revenue (2021-2032) & (US$ Million) Table 109. Mexico Tofacitinib Revenue (2021-2032) & (US$ Million) Table 110. Europe Tofacitinib Revenue by Type (2021-2026) & (US$ Million) Table 111. Europe Tofacitinib Revenue by Type (2027-2032) & (US$ Million) Table 112. Europe Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 113. Europe Tofacitinib Sales by Type (2027-2032) & (k pcs) Table 114. Europe Tofacitinib Sales Price by Type (2021-2026) & (US$/pcs) Table 115. Europe Tofacitinib Sales Price by Type (2027-2032) & (US$/pcs) Table 116. Europe Tofacitinib Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Tofacitinib Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 119. Europe Tofacitinib Sales by Application (2027-2032) & (k pcs) Table 120. Europe Tofacitinib Sales Price by Application (2021-2026) & (US$/pcs) Table 121. Europe Tofacitinib Sales Price by Application (2027-2032) & (US$/pcs) Table 122. Europe Tofacitinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Europe Tofacitinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 124. Europe Tofacitinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 125. Europe Tofacitinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 126. Europe Tofacitinib Sales by Country (2021-2026) & (k pcs) Table 127. Europe Tofacitinib Sales by Country (2027-2032) & (k pcs) Table 128. Europe Tofacitinib Sales Price by Country (2021-2026) & (US$/pcs) Table 129. Europe Tofacitinib Sales Price by Country (2027-2032) & (US$/pcs) Table 130. Germany Tofacitinib Revenue (2021-2032) & (US$ Million) Table 131. France Tofacitinib Revenue (2021-2032) & (US$ Million) Table 132. U.K. Tofacitinib Revenue (2021-2032) & (US$ Million) Table 133. Italy Tofacitinib Revenue (2021-2032) & (US$ Million) Table 134. Russia Tofacitinib Revenue (2021-2032) & (US$ Million) Table 135. Spain Tofacitinib Revenue (2021-2032) & (US$ Million) Table 136. Netherlands Tofacitinib Revenue (2021-2032) & (US$ Million) Table 137. Switzerland Tofacitinib Revenue (2021-2032) & (US$ Million) Table 138. Sweden Tofacitinib Revenue (2021-2032) & (US$ Million) Table 139. Poland Tofacitinib Revenue (2021-2032) & (US$ Million) Table 140. China Tofacitinib Revenue by Type (2021-2026) & (US$ Million) Table 141. China Tofacitinib Revenue by Type (2027-2032) & (US$ Million) Table 142. China Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 143. China Tofacitinib Sales by Type (2027-2032) & (k pcs) Table 144. China Tofacitinib Sales Price by Type (2021-2026) & (US$/pcs) Table 145. China Tofacitinib Sales Price by Type (2027-2032) & (US$/pcs) Table 146. China Tofacitinib Revenue by Application (2021-2026) & (US$ Million) Table 147. China Tofacitinib Revenue by Application (2027-2032) & (US$ Million) Table 148. China Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 149. China Tofacitinib Sales by Application (2027-2032) & (k pcs) Table 150. China Tofacitinib Sales Price by Application (2021-2026) & (US$/pcs) Table 151. China Tofacitinib Sales Price by Application (2027-2032) & (US$/pcs) Table 152. Asia Tofacitinib Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Tofacitinib Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 155. Asia Tofacitinib Sales by Type (2027-2032) & (k pcs) Table 156. Asia Tofacitinib Sales Price by Type (2021-2026) & (US$/pcs) Table 157. Asia Tofacitinib Sales Price by Type (2027-2032) & (US$/pcs) Table 158. Asia Tofacitinib Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Tofacitinib Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 161. Asia Tofacitinib Sales by Application (2027-2032) & (k pcs) Table 162. Asia Tofacitinib Sales Price by Application (2021-2026) & (US$/pcs) Table 163. Asia Tofacitinib Sales Price by Application (2027-2032) & (US$/pcs) Table 164. Asia Tofacitinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Tofacitinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Tofacitinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Tofacitinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 168. Asia Tofacitinib Sales by Country (2021-2026) & (k pcs) Table 169. Asia Tofacitinib Sales by Country (2027-2032) & (k pcs) Table 170. Asia Tofacitinib Sales Price by Country (2021-2026) & (US$/pcs) Table 171. Asia Tofacitinib Sales Price by Country (2027-2032) & (US$/pcs) Table 172. Japan Tofacitinib Revenue (2021-2032) & (US$ Million) Table 173. South Korea Tofacitinib Revenue (2021-2032) & (US$ Million) Table 174. India Tofacitinib Revenue (2021-2032) & (US$ Million) Table 175. Australia Tofacitinib Revenue (2021-2032) & (US$ Million) Table 176. Taiwan Tofacitinib Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Tofacitinib Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Tofacitinib Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Tofacitinib Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Tofacitinib Sales by Type (2021-2026) & (k pcs) Table 181. SAMEA Tofacitinib Sales by Type (2027-2032) & (k pcs) Table 182. SAMEA Tofacitinib Sales Price by Type (2021-2026) & (US$/pcs) Table 183. SAMEA Tofacitinib Sales Price by Type (2027-2032) & (US$/pcs) Table 184. SAMEA Tofacitinib Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Tofacitinib Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Tofacitinib Sales by Application (2021-2026) & (k pcs) Table 187. SAMEA Tofacitinib Sales by Application (2027-2032) & (k pcs) Table 188. SAMEA Tofacitinib Sales Price by Application (2021-2026) & (US$/pcs) Table 189. SAMEA Tofacitinib Sales Price by Application (2027-2032) & (US$/pcs) Table 190. SAMEA Tofacitinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Tofacitinib Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Tofacitinib Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Tofacitinib Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 194. SAMEA Tofacitinib Sales by Country (2021-2026) & (k pcs) Table 195. SAMEA Tofacitinib Sales by Country (2027-2032) & (k pcs) Table 196. SAMEA Tofacitinib Sales Price by Country (2021-2026) & (US$/pcs) Table 197. SAMEA Tofacitinib Sales Price by Country (2027-2032) & (US$/pcs) Table 198. Brazil Tofacitinib Revenue (2021-2032) & (US$ Million) Table 199. Argentina Tofacitinib Revenue (2021-2032) & (US$ Million) Table 200. Chile Tofacitinib Revenue (2021-2032) & (US$ Million) Table 201. Colombia Tofacitinib Revenue (2021-2032) & (US$ Million) Table 202. Peru Tofacitinib Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Tofacitinib Revenue (2021-2032) & (US$ Million) Table 204. Israel Tofacitinib Revenue (2021-2032) & (US$ Million) Table 205. UAE Tofacitinib Revenue (2021-2032) & (US$ Million) Table 206. Turkey Tofacitinib Revenue (2021-2032) & (US$ Million) Table 207. Iran Tofacitinib Revenue (2021-2032) & (US$ Million) Table 208. Egypt Tofacitinib Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Tofacitinib Distributors List Table 212. Tofacitinib Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Tofacitinib Image Figure 2. Global Tofacitinib Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tofacitinib Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5mg*60 Tablets Image Figure 5. 5mg*30 Tablets Image Figure 6. 5mg*14 Tablets Image Figure 7. 5mg*10 Tablets Image Figure 8. 10mg*14 Tablets Image Figure 9. 10mg*10 Tablets Image Figure 10. Global Tofacitinib Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Tofacitinib Market Size Share 2021 VS 2025 VS 2032 Figure 12. Psoriasis Image Figure 13. Rheumatoid Arthritis Image Figure 14. Ulcerative Colitis Image Figure 15. Others Image Figure 16. Global Tofacitinib Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Tofacitinib Revenue (2021-2032) & (US$ Million) Figure 18. Global Tofacitinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Tofacitinib Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Tofacitinib Revenue Market Share by Region (2021-2032) Figure 21. Global Tofacitinib Sales (2021-2032) & (k pcs) Figure 22. Global Tofacitinib Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 23. Global Tofacitinib Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Tofacitinib Sales YoY (2021-2032) & (k pcs) Figure 25. Europe Tofacitinib Sales YoY (2021-2032) & (k pcs) Figure 26. China Tofacitinib Sales YoY (2021-2032) & (k pcs) Figure 27. Asia (Excluding China) Tofacitinib Sales YoY (2021-2032) & (k pcs) Figure 28. South America, Middle East and Africa Tofacitinib Sales YoY (2021-2032) & (k pcs) Figure 29. Global Tofacitinib Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Tofacitinib Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Tofacitinib Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Tofacitinib Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Tofacitinib Revenue Market Share by Type (2021-2032) Figure 35. Global Tofacitinib Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 36. Global Tofacitinib Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Tofacitinib Sales Market Share by Type (2021-2032) Figure 38. Global Tofacitinib Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Tofacitinib Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Tofacitinib Revenue Market Share by Application (2021-2032) Figure 41. Global Tofacitinib Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 42. Global Tofacitinib Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Tofacitinib Sales Market Share by Application (2021-2032) Figure 44. North America Tofacitinib Revenue Share by Type (2021-2032) Figure 45. North America Tofacitinib Sales Share by Type (2021-2032) Figure 46. North America Tofacitinib Revenue Share by Application (2021-2032) Figure 47. North America Tofacitinib Sales Share by Application (2021-2032) Figure 48. North America Tofacitinib Revenue Share by Country (2021-2032) Figure 49. North America Tofacitinib Sales Share by Country (2021-2032) Figure 50. Europe Tofacitinib Revenue Share by Type (2021-2032) Figure 51. Europe Tofacitinib Sales Share by Type (2021-2032) Figure 52. Europe Tofacitinib Revenue Share by Application (2021-2032) Figure 53. Europe Tofacitinib Sales Share by Application (2021-2032) Figure 54. Europe Tofacitinib Revenue Share by Country (2021-2032) Figure 55. Europe Tofacitinib Sales Share by Country (2021-2032) Figure 56. China Tofacitinib Revenue Share by Type (2021-2032) Figure 57. China Tofacitinib Sales Share by Type (2021-2032) Figure 58. China Tofacitinib Revenue Share by Application (2021-2032) Figure 59. China Tofacitinib Sales Share by Application (2021-2032) Figure 60. Asia Tofacitinib Revenue Share by Type (2021-2032) Figure 61. Asia Tofacitinib Sales Share by Type (2021-2032) Figure 62. Asia Tofacitinib Revenue Share by Application (2021-2032) Figure 63. Asia Tofacitinib Sales Share by Application (2021-2032) Figure 64. Asia Tofacitinib Revenue Share by Country (2021-2032) Figure 65. Asia Tofacitinib Sales Share by Country (2021-2032) Figure 66. SAMEA Tofacitinib Revenue Share by Type (2021-2032) Figure 67. SAMEA Tofacitinib Sales Share by Type (2021-2032) Figure 68. SAMEA Tofacitinib Revenue Share by Application (2021-2032) Figure 69. SAMEA Tofacitinib Sales Share by Application (2021-2032) Figure 70. SAMEA Tofacitinib Revenue Share by Country (2021-2032) Figure 71. SAMEA Tofacitinib Sales Share by Country (2021-2032) Figure 72. Tofacitinib Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Tofacitinib Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg*60 Tablets
  • 5mg*30 Tablets
  • 5mg*14 Tablets
  • 5mg*10 Tablets
  • 10mg*14 Tablets
  • 10mg*10 Tablets
Applications
  • Psoriasis
  • Rheumatoid Arthritis
  • Ulcerative Colitis
  • Others
Companies covered
  • Pfizer
  • Globe Pharmaceuticals
  • Drug International
  • Delta Pharma Limited
  • Beacon Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Tofacitinib Market by Type
  3. 1.2.1 Global Tofacitinib Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5mg*60 Tablets
  5. 1.2.3 5mg*30 Tablets
  6. 1.2.4 5mg*14 Tablets
  7. 1.2.5 5mg*10 Tablets
  8. 1.2.6 10mg*14 Tablets
  9. 1.2.7 10mg*10 Tablets
  10. 1.3 Tofacitinib Market by Application
  11. 1.3.1 Global Tofacitinib Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Psoriasis
  13. 1.3.3 Rheumatoid Arthritis
  14. 1.3.4 Ulcerative Colitis
  15. 1.3.5 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Tofacitinib Market Dynamics
  1. 2.1 Tofacitinib Industry Trends
  2. 2.2 Tofacitinib Industry Drivers
  3. 2.3 Tofacitinib Industry Opportunities and Challenges
  4. 2.4 Tofacitinib Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Tofacitinib Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Tofacitinib Revenue by Region
  3. 3.2.1 Global Tofacitinib Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Tofacitinib Revenue by Region (2021-2026)
  5. 3.2.3 Global Tofacitinib Revenue by Region (2027-2032)
  6. 3.2.4 Global Tofacitinib Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Tofacitinib Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Tofacitinib Sales by Region
  9. 3.4.1 Global Tofacitinib Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Tofacitinib Sales by Region (2021-2026)
  11. 3.4.3 Global Tofacitinib Sales by Region (2027-2032)
  12. 3.4.4 Global Tofacitinib Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Tofacitinib Revenue by Manufacturers
  2. 4.1.1 Global Tofacitinib Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Tofacitinib Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Tofacitinib Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Tofacitinib Sales by Manufacturers
  6. 4.2.1 Global Tofacitinib Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Tofacitinib Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Tofacitinib Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Tofacitinib Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Tofacitinib Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Tofacitinib Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Tofacitinib Manufacturers, Product Type & Application
  13. 4.7 Global Tofacitinib Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Tofacitinib Market CR5 and HHI
  16. 4.8.2 2025 Tofacitinib Tier 1, Tier 2, and Tier 3
5 Tofacitinib Market by Type
  1. 5.1 Global Tofacitinib Revenue by Type
  2. 5.1.1 Global Tofacitinib Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Tofacitinib Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Tofacitinib Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Tofacitinib Sales by Type
  6. 5.2.1 Global Tofacitinib Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tofacitinib Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Tofacitinib Sales Market Share by Type (2021-2032)
  9. 5.3 Global Tofacitinib Price by Type
6 Tofacitinib Market by Application
  1. 6.1 Global Tofacitinib Revenue by Application
  2. 6.1.1 Global Tofacitinib Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Tofacitinib Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Tofacitinib Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Tofacitinib Sales by Application
  6. 6.2.1 Global Tofacitinib Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Tofacitinib Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Tofacitinib Sales Market Share by Application (2021-2032)
  9. 6.3 Global Tofacitinib Price by Application
7 Company Profiles
  1. 7.1 Pfizer
  2. 7.1.1 Pfizer Company Information
  3. 7.1.2 Pfizer Business Overview
  4. 7.1.3 Pfizer Tofacitinib Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Pfizer Tofacitinib Product Portfolio
  6. 7.1.5 Pfizer Recent Developments
  7. 7.2 Globe Pharmaceuticals
  8. 7.2.1 Globe Pharmaceuticals Company Information
  9. 7.2.2 Globe Pharmaceuticals Business Overview
  10. 7.2.3 Globe Pharmaceuticals Tofacitinib Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Globe Pharmaceuticals Tofacitinib Product Portfolio
  12. 7.2.5 Globe Pharmaceuticals Recent Developments
  13. 7.3 Drug International
  14. 7.3.1 Drug International Company Information
  15. 7.3.2 Drug International Business Overview
  16. 7.3.3 Drug International Tofacitinib Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Drug International Tofacitinib Product Portfolio
  18. 7.3.5 Drug International Recent Developments
  19. 7.4 Delta Pharma Limited
  20. 7.4.1 Delta Pharma Limited Company Information
  21. 7.4.2 Delta Pharma Limited Business Overview
  22. 7.4.3 Delta Pharma Limited Tofacitinib Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Delta Pharma Limited Tofacitinib Product Portfolio
  24. 7.4.5 Delta Pharma Limited Recent Developments
  25. 7.5 Beacon Pharmaceuticals
  26. 7.5.1 Beacon Pharmaceuticals Company Information
  27. 7.5.2 Beacon Pharmaceuticals Business Overview
  28. 7.5.3 Beacon Pharmaceuticals Tofacitinib Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Beacon Pharmaceuticals Tofacitinib Product Portfolio
  30. 7.5.5 Beacon Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Tofacitinib Market Size by Type
  2. 8.1.1 North America Tofacitinib Revenue by Type (2021-2032)
  3. 8.1.2 North America Tofacitinib Sales by Type (2021-2032)
  4. 8.1.3 North America Tofacitinib Price by Type (2021-2032)
  5. 8.2 North America Tofacitinib Market Size by Application
  6. 8.2.1 North America Tofacitinib Revenue by Application (2021-2032)
  7. 8.2.2 North America Tofacitinib Sales by Application (2021-2032)
  8. 8.2.3 North America Tofacitinib Price by Application (2021-2032)
  9. 8.3 North America Tofacitinib Market Size by Country
  10. 8.3.1 North America Tofacitinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Tofacitinib Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Tofacitinib Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Tofacitinib Market Size by Type
  2. 9.1.1 Europe Tofacitinib Revenue by Type (2021-2032)
  3. 9.1.2 Europe Tofacitinib Sales by Type (2021-2032)
  4. 9.1.3 Europe Tofacitinib Price by Type (2021-2032)
  5. 9.2 Europe Tofacitinib Market Size by Application
  6. 9.2.1 Europe Tofacitinib Revenue by Application (2021-2032)
  7. 9.2.2 Europe Tofacitinib Sales by Application (2021-2032)
  8. 9.2.3 Europe Tofacitinib Price by Application (2021-2032)
  9. 9.3 Europe Tofacitinib Market Size by Country
  10. 9.3.1 Europe Tofacitinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Tofacitinib Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Tofacitinib Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Tofacitinib Market Size by Type
  2. 10.1.1 China Tofacitinib Revenue by Type (2021-2032)
  3. 10.1.2 China Tofacitinib Sales by Type (2021-2032)
  4. 10.1.3 China Tofacitinib Price by Type (2021-2032)
  5. 10.2 China Tofacitinib Market Size by Application
  6. 10.2.1 China Tofacitinib Revenue by Application (2021-2032)
  7. 10.2.2 China Tofacitinib Sales by Application (2021-2032)
  8. 10.2.3 China Tofacitinib Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Tofacitinib Market Size by Type
  2. 11.1.1 Asia Tofacitinib Revenue by Type (2021-2032)
  3. 11.1.2 Asia Tofacitinib Sales by Type (2021-2032)
  4. 11.1.3 Asia Tofacitinib Price by Type (2021-2032)
  5. 11.2 Asia Tofacitinib Market Size by Application
  6. 11.2.1 Asia Tofacitinib Revenue by Application (2021-2032)
  7. 11.2.2 Asia Tofacitinib Sales by Application (2021-2032)
  8. 11.2.3 Asia Tofacitinib Price by Application (2021-2032)
  9. 11.3 Asia Tofacitinib Market Size by Country
  10. 11.3.1 Asia Tofacitinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Tofacitinib Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Tofacitinib Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Tofacitinib Market Size by Type
  2. 12.1.1 SAMEA Tofacitinib Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Tofacitinib Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Tofacitinib Price by Type (2021-2032)
  5. 12.2 SAMEA Tofacitinib Market Size by Application
  6. 12.2.1 SAMEA Tofacitinib Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Tofacitinib Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Tofacitinib Price by Application (2021-2032)
  9. 12.3 SAMEA Tofacitinib Market Size by Country
  10. 12.3.1 SAMEA Tofacitinib Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Tofacitinib Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Tofacitinib Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Tofacitinib Value Chain Analysis
  2. 13.1.1 Tofacitinib Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Tofacitinib Production Mode & Process
  6. 13.2 Tofacitinib Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Tofacitinib Distributors
  9. 13.2.3 Tofacitinib Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst